The Supreme Court announced three opinions this morning but none of them were the decisions most of the country was hoping for. When it took this case, the Supreme Court agreed to hear only one direct question, “Are human genes patentable?” The court, therefore, let stand the lower court decisions on all other questions. On this case there might be a compromise. The justices could strike down patents for isolated DNA but allow patents for manipulated complementary DNA strands. The result from this case may have little real world repercussions. Very few companies have a business model like Myriad, based on one single-gene patent, and Myriad’s patents are going to expire in a few years one way or another. communities.washingtontimes/neighborhood/political-potpourri/2013/jun/10/still-no-supreme-court-ruling-fisherwindsorperrymy/
Posted on: Mon, 10 Jun 2013 21:45:51 +0000